Back to Search Start Over

Serial decline in lung volume parameters on computed tomography (CT) predicts outcome in idiopathic pulmonary fibrosis (IPF).

Authors :
Robbie, Hasti
Wells, Athol U.
Fang, Cheng
Jacob, Joseph
Walsh, Simon L. F.
Nair, Arjun
Camoras, Rose
Desai, Sujal R.
Devaraj, Anand
Source :
European Radiology; Apr2022, Vol. 32 Issue 4, p2650-2660, 11p, 3 Black and White Photographs, 1 Diagram, 5 Charts, 2 Graphs
Publication Year :
2022

Abstract

<bold>Objectives: </bold>In patients with IPF, this study aimed (i) to examine the relationship between serial change in CT parameters of lung volume and lung function, (ii) to identify the prognostic value of serial change in CT parameters of lung volume, and (iii) to define a threshold for serial change in CT markers of lung volume that optimally captures disease progression.<bold>Methods: </bold>Serial CTs were analysed for progressive volume loss or fibrosis progression in 81 IPF patients (66 males, median age = 67 years) with concurrent forced vital capacity (FVC) (median follow-up 12 months, range 6-23 months). Serial CT measurements of volume loss comprised oblique fissure posterior retraction distance (OFPRD), aortosternal distance (ASD), lung height corrected for body habitus (LH), and automated CT-derived total lung volumes (ALV) (measured using commercially available software). Fibrosis progression was scored visually. Serial changes in CT markers and FVC were compared using regression analysis, and evaluated against mortality using Cox proportional hazards.<bold>Results: </bold>There were 58 deaths (72%, median survival = 17 months). Annual % change in ALV was most significantly related to annual % change in FVC (R2 = 0.26, p < 0.0001). On multivariate analysis, annual % change in ASD predicted mortality (HR = 0.97, p < 0.001), whereas change in FVC did not. A 25% decline in annual % change in ASD best predicted mortality, superior to 10% decline in FVC and fibrosis progression.<bold>Conclusion: </bold>In IPF, serial decline in CT markers of lung volume and, specifically, annualised 25% reduction in aortosternal distance provides evidence of disease progression, not always identified by FVC trends or changes in fibrosis extent.<bold>Key Points: </bold>• Serial decline in automated and surrogate markers of lung volume on CT corresponds to changes in FVC. • Annualised reductions in the distance between ascending aorta and posterior border of the sternum on CT predict mortality beyond annualised percentage change in FVC. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09387994
Volume :
32
Issue :
4
Database :
Complementary Index
Journal :
European Radiology
Publication Type :
Academic Journal
Accession number :
155758965
Full Text :
https://doi.org/10.1007/s00330-021-08338-2